I
InventisBio Co Ltd
SSE:688382
InventisBio Co Ltd
SSE:688382
Price:
22.63
CNY
6.39%
Market Closed
Market Cap:
¥13.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
InventisBio Co Ltd
SSE:688382
|
CN |
|
Foxconn Technology Co Ltd
TWSE:2354
|
TW |
|
Fuji PS Corp
TSE:1848
|
JP |
|
Scotts Miracle-Gro Co
NYSE:SMG
|
US |
|
Beiersdorf AG
XETRA:BEI
|
DE |
|
I
|
Information Planning Co Ltd
TSE:3712
|
JP |
|
Taiwan Fu Hsing Industrial Co Ltd
TWSE:9924
|
TW |
|
D
|
DC Healthcare Holdings Bhd
KLSE:DCHCARE
|
MY |
|
Plby Group Inc
NASDAQ:PLBY
|
US |
|
Z
|
Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
|
CN |
|
Y
|
Yoma Strategic Holdings Ltd
XBER:O3B
|
SG |
|
H
|
HSBC Holdings PLC
OTC:HBCYF
|
UK |
|
Electrolux Professional AB (publ)
STO:EPRO B
|
SE |
|
Sos Ltd
NYSE:SOS
|
CN |
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
CN |
|
S
|
Sepeda Bersama Indonesia Tbk PT
IDX:BIKE
|
ID |
Income Statement
Earnings Waterfall
InventisBio Co Ltd
InventisBio Co Ltd
Income Statement
InventisBio Co Ltd
InventisBio Co Ltd
Currency: CNY
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
1
|
0
|
1
|
1
|
1
|
2
|
2
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
80
N/A
|
127
+59%
|
186
+46%
|
194
+5%
|
120
-38%
|
78
-36%
|
169
+118%
|
168
0%
|
173
+3%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(4)
|
(6)
|
(7)
|
(4)
|
(1)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-155%
|
0
N/A
|
(0)
N/A
|
80
N/A
|
127
+59%
|
0
N/A
|
190
N/A
|
114
-40%
|
70
-38%
|
165
+134%
|
167
+1%
|
173
+3%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(358)
|
(405)
|
(430)
|
(503)
|
(520)
|
(523)
|
(543)
|
(493)
|
(510)
|
(483)
|
(483)
|
(457)
|
(437)
|
(413)
|
(345)
|
|
| Selling, General & Administrative |
(46)
|
(51)
|
(49)
|
(54)
|
(56)
|
(59)
|
(63)
|
(60)
|
(68)
|
(68)
|
(71)
|
(77)
|
(60)
|
(61)
|
(71)
|
|
| Research & Development |
(302)
|
(354)
|
(381)
|
(445)
|
(444)
|
(464)
|
(480)
|
(433)
|
(423)
|
(417)
|
(415)
|
(390)
|
(366)
|
(360)
|
(291)
|
|
| Depreciation & Amortization |
(15)
|
(5)
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
|
| Other Operating Expenses |
5
|
5
|
0
|
(4)
|
(0)
|
0
|
0
|
0
|
3
|
3
|
3
|
10
|
8
|
9
|
17
|
|
| Operating Income |
(358)
N/A
|
(405)
-13%
|
(430)
-6%
|
(503)
-17%
|
(520)
-3%
|
(523)
-1%
|
(463)
+11%
|
(366)
+21%
|
(325)
+11%
|
(293)
+10%
|
(369)
-26%
|
(386)
-5%
|
(272)
+29%
|
(245)
+10%
|
(172)
+30%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
0
|
(6)
|
15
|
27
|
36
|
42
|
37
|
26
|
41
|
44
|
38
|
38
|
32
|
31
|
27
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(358)
N/A
|
(411)
-15%
|
(416)
-1%
|
(476)
-14%
|
(483)
-2%
|
(481)
+0%
|
(426)
+12%
|
(340)
+20%
|
(284)
+16%
|
(249)
+12%
|
(330)
-33%
|
(348)
-5%
|
(240)
+31%
|
(215)
+11%
|
(145)
+32%
|
|
| Net Income | ||||||||||||||||
| Income from Continuing Operations |
(358)
|
(411)
|
(416)
|
(476)
|
(483)
|
(481)
|
(426)
|
(340)
|
(284)
|
(249)
|
(330)
|
(348)
|
(240)
|
(215)
|
(145)
|
|
| Net Income (Common) |
(358)
N/A
|
(411)
-15%
|
(416)
-1%
|
(476)
-14%
|
(483)
-2%
|
(481)
+0%
|
(426)
+12%
|
(340)
+20%
|
(284)
+16%
|
(249)
+12%
|
(330)
-33%
|
(348)
-5%
|
(240)
+31%
|
(215)
+11%
|
(145)
+32%
|
|
| EPS (Diluted) |
-0.62
N/A
|
-0.71
-15%
|
-0.72
-1%
|
-0.82
-14%
|
-0.84
-2%
|
-0.83
+1%
|
-0.74
+11%
|
-0.59
+20%
|
-0.49
+17%
|
-0.43
+12%
|
-0.57
-33%
|
-0.6
-5%
|
-0.42
+30%
|
-0.38
+10%
|
-0.26
+32%
|
|
Switch to:
Switch to:
See Also
Discover More
